Some time ago, you decided to switch from paper to an eClinical system. But now that you've been with that provider for a while, does your relationship feel a bit...strained?
Merge to become part of IBM’s new Watson Health business unit
Armonk, NY and CHICAGO – 13 Oct, 2015: IBM (NYSE: IBM) today announced that it has completed the acquisition of Merge Healthcare Incorporated, a leading provider of medical image handling and processing, interoperability and clinical systems. Under terms of the $1 billion transaction, Merge shareholders will receive $7.13 per share in cash.
eClinicalOS Welcomes Watson!
The hallways at eClinicalOS headquarters are positively buzzing this week! Why the fuss? Well, we just got some VERY exciting news about our future. (We think you’ll find it to be great news, too!)
Compliance with self-inspection mandate required by August 25th
The China Food and Drug Administration (CFDA) is making a push to ensure the accuracy of clinical trial data and drug quality (as well as proper record-keeping) for its 1,622 currently pending drug registration applications. This includes both imported and local drugs.
It’s no secret that clinical trials are a world-wide operation. Which markets are the hottest right now?
The objective of work is to get things done. Simple, right?
But perpetual phone calls, endless emails and mind-numbing meetings (not to mention hundreds of other daily distractions) can quickly complicate matters and sap productivity. Which leads to more stress and frustration. Which, in turn, leads to lower productivity.
Feeling a strange sense of déjà vu all over again?
If there’s one thing we prize at eClinicalOS, it’s efficiency. After all, we built our company around the concept of helping clinical researchers work smarter through advanced information technology. So it’s only natural that we relentlessly search for ways to be more efficient ourselves. And when we discover them, we’re eager to share them.
The Top Line:
- Cost reduction measures can be implemented in different phases of a clinical trial and may be direct or indirect in nature.
- EDC and eClinical platforms offer multiple opportunities to reduce costs and increase efficiency.
- Thoughtful negotiation and understanding of contract models is essential to avoiding budget overruns.
Trimming study budgets is a good thing, right? Well, yes and no. When you can cut costs without compromising data integrity or accuracy, that's usually a good thing. But when cost cutting is only about saving money no matter what, it can increase frustration, impair quality, damage reputations and end up increasing project costs in the long run.
The Top Line:
- Reach out to the industry to learn about available systems.
- System pricing runs the range, as do productivity savings.
- Full-featured product demonstrations let you drive before you buy.
When it comes to selecting an EDC provider, your choice will depend on a range of factors and needs. Usage requirements to efficiently perform the functions and tasks required for successful project delivery, and your budget, will be prominent decision points. But where to start?
Even with the plug-and-play operability of SaaS systems, three steps can guide your assessment and help shorten the time between thinking about system vendor options and executing your first study
The Top Line:
- Easily prevented mistakes can delay realizing EDC’s benefits
- Effective EDC adoption requires careful planning and a step-by-step strategy
- Adopting best practices can blunt seven common EDC missteps
Picture this: Your organization just selected a killer EDC platform, and you are ready to build and launch your first study. Your team’s been trained, the logins and passwords are set, and everyone’s primed to get this puppy up and running. Greater efficiencies, bigger savings and faster trials are just around the corner!!
Unless, of course, they’re not.
Thing is, we’re all human, and we all make mistakes from time to time. Mistakes executing your first few EDC studies are not out of the realm of possibility, and those mistakes can delay realizing the system’s benefits (and cause massive frustration across the research team).
But with a little planning and preparation, you can sidestep the most common potholes of moving from paper to Cloud-based studies. Avoid these “Seven Deadly Sins of EDC Adoption,” and you’ll find yourself up and running at full EDC speed in a matter of weeks instead spinning your wheels in a roadside ditch.
The Top Line:
- More than 70 percent of clinical trials now use some form of EDC
- Cloud-based EDC platforms offer significant benefits for all sizes and types of organizations
- Selecting the best system for you requires careful due diligence in five key areas
If there is an EDC genie, he’s permanently been let out of the bottle.
Well over 70 percent of clinical trials now use Electronic Data Collection (EDC) in some fashion since the first systems appeared a decade ago. And even if the pharmaceutical and medical device industry is historically slow to adopt new technology, the ease, efficiency and cost-effectiveness of cloud-based EDC platforms are encouraging upgrades across the sector.
CROs and investigator site early adopters, particularly in the U.S. and Europe, are taking the next step in clinical IT’s evolution: They’re moving away from older proprietary, server-based EDC systems, spurred on by streamlined data collection that improves data security, quality and access. This trend is especially evident among small and medium-size sponsors, CROs and academic research institutions that lack the capital needed to purchase, install and maintain server-based systems. And the market has responded as EDC vendors have added cloud-based tools to their product and service suites.